Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation.
Andrea-Hermina GyörfiAlexandru Emil MateiMaximilian FuchsChunguang LiangAleix Rius RigauXuezhi HongHonglin ZhuMarkus LuberChristina BergmannClara DeesIngo LudolphRaymund E HorchOliver DistlerJiucun WangBertram BengschLarissa Valor-MéndezMeik KunzJörg H W DistlerPublished in: The Journal of experimental medicine (2021)
Transforming growth factor-β (TGFβ) is a key mediator of fibroblast activation in fibrotic diseases, including systemic sclerosis. Here we show that Engrailed 1 (EN1) is reexpressed in multiple fibroblast subpopulations in the skin of SSc patients. We characterize EN1 as a molecular amplifier of TGFβ signaling in myofibroblast differentiation: TGFβ induces EN1 expression in a SMAD3-dependent manner, and in turn, EN1 mediates the profibrotic effects of TGFβ. RNA sequencing demonstrates that EN1 induces a profibrotic gene expression profile functionally related to cytoskeleton organization and ROCK activation. EN1 regulates gene expression by modulating the activity of SP1 and other SP transcription factors, as confirmed by ChIP-seq experiments for EN1 and SP1. Functional experiments confirm the coordinating role of EN1 on ROCK activity and the reorganization of cytoskeleton during myofibroblast differentiation, in both standard fibroblast culture systems and in vitro skin models. Consistently, mice with fibroblast-specific knockout of En1 demonstrate impaired fibroblast-to-myofibroblast transition and are partially protected from experimental skin fibrosis.
Keyphrases
- transforming growth factor
- epithelial mesenchymal transition
- systemic sclerosis
- gene expression
- wound healing
- transcription factor
- signaling pathway
- poor prognosis
- metabolic syndrome
- newly diagnosed
- dna methylation
- type diabetes
- genome wide
- patient reported outcomes
- prognostic factors
- circulating tumor cells
- skeletal muscle
- insulin resistance
- sensitive detection
- drug induced